Levocetirizine and montelukast in the COVID-19 treatment paradigm

Levocetirizine, a third-generation antihistamine, and montelukast, a leukotriene receptor antagonist, exhibit remarkable synergistic anti-inflammatory activity across a spectrum of signaling proteins, cell adhesion molecules, and leukocytes. By targeting cellular protein activity, they are uniquely...

Descripción completa

Detalles Bibliográficos
Autores principales: May, Bruce Chandler, Gallivan, Kathleen Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673734/
https://www.ncbi.nlm.nih.gov/pubmed/34942461
http://dx.doi.org/10.1016/j.intimp.2021.108412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673734/
https://www.ncbi.nlm.nih.gov/pubmed/34942461
http://dx.doi.org/10.1016/j.intimp.2021.108412

Ejemplares similares